Personalizing decision-making for persons with Parkinson’s disease: where do we stand and what to improve?

被引:0
|
作者
Lieneke van den Heuvel
Marjan J. Meinders
Bart Post
Bastiaan R. Bloem
Anne M. Stiggelbout
机构
[1] Radboud University Medical Centre,Donders Institute for Brain, Cognition and Behaviour Department of Neurology Centre of Expertise for Parkinson & Movement Disorders
[2] Radboud University Medical Centre,Scientific Centre for Quality of Healthcare, Centre of Expertise for Parkinson & Movement Disorders
[3] Radboud Institute for Health Sciences,Medical Decision Making, Department of Biomedical Data Sciences
[4] Leiden University Medical Centre,undefined
来源
Journal of Neurology | 2022年 / 269卷
关键词
Clinical decision-making; Parkinson’s disease; Personalized decision-making; Personalized medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3569 / 3578
页数:9
相关论文
共 50 条
  • [1] Personalizing decision-making for persons with Parkinson's disease: where do we stand and what to improve?
    van den Heuvel, Lieneke
    Meinders, Marjan J.
    Post, Bart
    Bloem, Bastiaan R.
    Stiggelbout, Anne M.
    JOURNAL OF NEUROLOGY, 2022, 269 (07) : 3569 - 3578
  • [2] Progress in Parkinson's disease - Where do we stand?
    Toulouse, Andre
    Sullivan, Aideen M.
    PROGRESS IN NEUROBIOLOGY, 2008, 85 (04) : 376 - 392
  • [3] Where do we stand in the treatment of Parkinson's disease?
    Yoshikuni Mizuno
    Journal of Neurology, 2007, 254 : 13 - 18
  • [4] Where do we stand in the treatment of Parkinson's disease?
    Mizuno, Yoshikuni
    JOURNAL OF NEUROLOGY, 2007, 254 : 13 - 18
  • [5] Stem cell therapy for Parkinson's disease: where do we stand?
    Roybon, L
    Christophersen, NS
    Brundin, P
    Li, JY
    CELL AND TISSUE RESEARCH, 2004, 318 (01) : 261 - 273
  • [6] Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?
    Virameteekul, Sasivimol
    Revesz, Tamas
    Jaunmuktane, Zane
    Warner, Thomas T.
    De Pablo-Fernandez, Eduardo
    MOVEMENT DISORDERS, 2023, 38 (04) : 558 - 566
  • [7] Stem cell therapy for Parkinson’s disease: where do we stand?
    Laurent Roybon
    Nicolaj S. Christophersen
    Patrik Brundin
    Jia-Yi Li
    Cell and Tissue Research, 2004, 318 : 261 - 273
  • [8] Impaired decision-making in Parkinson's disease
    Mimura, M
    Oeda, R
    Kawamura, M
    PARKINSONISM & RELATED DISORDERS, 2006, 12 (03) : 169 - 175
  • [9] Perceptual decision-making in patients with Parkinson's disease
    Djamshidian, Atbin
    O'Sullivan, Sean S.
    Lawrence, Andrew D.
    Foltynie, Thomas
    Aviles-Olmos, Iciar
    Magdalinou, Nadia
    Tomassini, Alessandro
    Warner, Thomas T.
    Lees, Andrew J.
    Averbeck, Bruno B.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (12) : 1149 - 1154
  • [10] LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
    Taymans, Jean-Marc
    Greggio, Elisa
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (03) : 214 - 225